2cureX AB (OSTO:2CUREX) FCF Yield % : -481.39 (As of May. 20, 2024)

View and export this data going back to 2017. Start your Free Trial

What is 2cureX AB FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, 2cureX AB's Trailing 12-Month Free Cash Flow is kr-29.83 Mil, and Market Cap is kr6.20 Mil. Therefore, 2cureX AB's FCF Yield % for today is -481.39%.

The historical rank and industry rank for 2cureX AB's FCF Yield % or its related term are showing as below:

OSTO:2CUREX' s FCF Yield % Range Over the Past 10 Years
Min: -584.29 Med: 1.35 Max: 9.47
Current: -481.39

During the past 8 years, the highest FCF Yield % of 2cureX AB was 9.47%. The lowest was -584.29%. And the median was 1.35%.

OSTO:2CUREX's FCF Yield % is ranked worse than
96.34% of 1557 companies
in the Biotechnology industry
Industry Median: -14.1 vs OSTO:2CUREX: -481.39

2cureX AB's FCF Margin % for the quarter that ended in Sep. 2023 was -8,883.91%.

2cureX AB FCF Yield % Historical Data

The historical data trend for 2cureX AB's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

2cureX AB FCF Yield % Chart

2cureX AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Yield %

Get a 7-Day Free Trial

-0.03

-4.67

-4.92

-6.29

-19.88

2cureX AB Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
FCF Yield %	Get a 7-Day Free Trial															-18.67	-8.11	-36.38	-49.18	-54.21

Competitive Comparison of 2cureX AB's FCF Yield %

For the Biotechnology subindustry, 2cureX AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

2cureX AB's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 2cureX AB's FCF Yield % distribution charts can be found below:

* The bar in red indicates where 2cureX AB's FCF Yield % falls into.

2cureX AB FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

2cureX AB's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-28.525	/	143.463635
	=	-19.88%

2cureX AB's annualized FCF Yield % for the quarter that ended in Sep. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-7.729	*	4	/	57.033396
	=	-54.21%

2cureX AB FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

2cureX AB FCF Yield % Related Terms

Thank you for viewing the detailed overview of 2cureX AB's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

2cureX AB (OSTO:2CUREX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 2cureX AB (OSTO:2CUREX) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

2QE:Germany

Address

Fruebjergvej 3, Copenhagen, DNK, DK-2100

Website

https://www.2curex.com

2cureX AB is a biotech company. The company is engaged in improving treatment efficiency, mainly for cancer patients. It is involved in developing a product, namely IndiTreat, which is a technology for the treatment of colorectal, ovarian, and pancreatic cancers. The company's sub-products include IndiTreat Test, IndiTreat clinical programs, and IndiTreat Therapy Design.

2cureX AB (OSTO:2CUREX) Headlines

No Headlines